Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Frassoni

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Leukemia Research|February 19, 2013
Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemiaDaniela Cilloni, Sonia Carturan, Enrico Bracco, et al.
Biomarker Research|July 7, 2015
Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISHValentina Rosso, Enrico Bracco, Roberto Pedrola, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantationStefania Coppoletta, Elisabetta Tedone, Barbara Galano, et al.
Blood|June 12, 2004
Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)Laurent Garderet, Myriam Labopin, Norbert-Claude Gorin, et al.
Haematologica|July 5, 2006
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantationAlessandra Larocca, Giovanna Piaggio, Marina Podestà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patientsIlaria Iacobucci, Giuseppe Saglio, Gianantonio Rosti, et al.
Journal of Clinical Medicine|June 5, 2020
Transplantation Induces Profound Changes in the Transcriptional Asset of Hematopoietic Stem Cells: Identification of Specific Signatures Using Machine Learning TechniquesDaniela Cilloni, Jessica Petiti, Valentina Campia, et al.
International Journal of Molecular Sciences|October 21, 2020
Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic CellsChiara Calabrese, Cristina Panuzzo, Serena Stanga, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 20, 2017
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cellsFrancesco La Rocca, Irma Airoldi, Emma Di Carlo, et al.
Blood|July 25, 2009
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality markerGiovanna Piaggio, Vittorio Rosti, Mirko Corselli, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Leukemia Research|February 19, 2013
Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemiaDaniela Cilloni, Sonia Carturan, Enrico Bracco, et al.
Biomarker Research|July 7, 2015
Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISHValentina Rosso, Enrico Bracco, Roberto Pedrola, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantationStefania Coppoletta, Elisabetta Tedone, Barbara Galano, et al.
Blood|June 12, 2004
Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)Laurent Garderet, Myriam Labopin, Norbert-Claude Gorin, et al.
Haematologica|July 5, 2006
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantationAlessandra Larocca, Giovanna Piaggio, Marina Podestà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patientsIlaria Iacobucci, Giuseppe Saglio, Gianantonio Rosti, et al.
Journal of Clinical Medicine|June 5, 2020
Transplantation Induces Profound Changes in the Transcriptional Asset of Hematopoietic Stem Cells: Identification of Specific Signatures Using Machine Learning TechniquesDaniela Cilloni, Jessica Petiti, Valentina Campia, et al.
International Journal of Molecular Sciences|October 21, 2020
Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic CellsChiara Calabrese, Cristina Panuzzo, Serena Stanga, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 20, 2017
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cellsFrancesco La Rocca, Irma Airoldi, Emma Di Carlo, et al.
Blood|July 25, 2009
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality markerGiovanna Piaggio, Vittorio Rosti, Mirko Corselli, et al.
Pageof 11